A non-synonymous polymorphism in galectin-3 lectin domain is associated with allergic reactions to beta-lactam antibiotics

Autor: Natalia Blanca-Lopez, Jean-Louis Guéant, M.J. Torres, Antonino Romano, Inmaculada Doña, Gabriela Canto, Thomas Josse, D. Tramoy, Rosa-Maria Guéant-Rodriguez, Jose A. Cornejo-Garcia, Abderrahim Oussalah, Francesco Gaeta, M. Blanca
Přispěvatelé: Nutrition-Génétique et Exposition aux Risques Environnementaux (NGERE), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Biomedical Research Institute of Málaga (IBIMA), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Complesso Integrato Columbus, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS)
Rok vydání: 2015
Předmět:
Zdroj: Pharmacogenomics Journal
Pharmacogenomics Journal, Nature Publishing Group, 2016, 16 (1), pp.79-82. ⟨10.1038/tpj.2015.24⟩
ISSN: 1473-1150
1470-269X
Popis: International audience; Genetic predictors of beta-lactam (BL) allergy are mostly related to Immunoglobulin E (IgE) synthesis and atopy. Despite this context, little attention has been devoted to genes of IgE/Fc epsilon RI pathway, such as galectin-3, a beta-galactoside-binding lectin, which binds to IgE. We evaluated the association of LGALS3 polymorphisms with BL allergy in 395 Spanish and 198 Italian cases, compared with 310- and 339-matched controls, respectively. The rs11125 predicted BL allergy with an odds ratio of 4.0 in Spanish population (PHis substitution produced by rs11125 on galactose-binding activity of galectin-3. In conclusion, LGALS3 is the strongest genetic predictor of BL allergy reported so far. This association reflects the influence of genes of IgE/Fc epsilon RI pathway in this pathology.
Databáze: OpenAIRE